Related Experiment Videos
May children with recurrent respiratory infections be a test bed of immunomodulators?
M de Martino1, L Galli, A Vierucci
1Department of Pediatrics, University of Florence, Italy.
Pharmacological Research
|September 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Quantitative shape analysis of chemoresistant colon cancer cells: correlation between morphotype and phenotype.
Experimental cell research·2012
Intracardiac left atrial tuberculoma in an eleven-month-old infant: case report.
BMC infectious diseases·2012
Genotypic characterization of non-O157 Shiga toxin-producing Escherichia coli in beef abattoirs of Argentina.
Journal of food protection·2011
New limit on the lepton-flavor-violating decay μ+→e+γ.
Physical review letters·2011
Natural killer cell deficiencies in a consecutive series of children with herpetic encephalitis.
International journal of immunopathology and pharmacology·2011
Therapeutic management of bacterial meningitis in children: a systematic review and comparison of published guidelines from a European perspective.
Journal of chemotherapy (Florence, Italy)·2010
NRF2 Signalling in Endometriosis: A Hormone-Independent Axis for Fertility-Preserving Therapeutic Innovation.
Pharmacological research·2026
Targeting the ChREBP/PKLR-lactate axis via Huachansu tablets restores CD8⁺T cell immunity in MASH-HCC.
Pharmacological research·2026
NMN Mitigates LPS-Induced Liver Injury by Inhibiting Ferroptosis via Suppression of the cGAS-STING-ACSL4 Axis.
Pharmacological research·2026
High prevalence of autoantibodies neutralizing type I IFNs in Japanese patients with hepatitis C.
Journal of human immunity·2026
Immunosenescence and immune-organ axis dysfunction: Potential of algal bioactives and nutritional interventions for healthy ageing.
International reviews of immunology·2026
Brief Communication: LSD1 Inhibition Enhances Susceptibility of Primary AML Cells for NK Cell-Mediated Killing.
Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Somatic Hypermutations Enhance Neutralization Breadth of IGHV3-53/3-66 Public Antibodies Against SARS-CoV-2 Variants.
Immunity, inflammation and disease·2026